Precigen
PGEN · listed on Nasdaq · worth $2.21 billion
One insider buy in the last year, $24.7K in all. None in the last two weeks.
Green dot = an insider bought red = soldA number = that many on nearby days · click a mark to see who, or read the filing
Company insiders
In the last year, one insider bought Precigen stock and seven insiders sold. Six of the 31 sales are marked on the filing as planned in advance. The biggest seller was Randal J. Kirk.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
Nancy H. Agee
Bought $24.7K on Aug 21 — 3,411 shares at $7.23, 1.1% of what they now own.
Planned sales
Form 144 notices filed for Precigen in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
Director Jeffrey B. Kindler filed to sell 185,000 shares on 26 Aug; sold 185,000 by 26 AugNotice on SEC.gov
Executive Phil Tennant filed to sell 79,166 shares on 25 Aug; sold 79,166 by 25 Aug10b5-1 plan adopted 31 Mar 2026 · Notice on SEC.gov
COO Rutul R. Shah filed to sell 15,342 shares on 25 Aug; sold 15,342 by 25 Aug10b5-1 plan adopted 31 Mar 2026 · Notice on SEC.gov
Big investors
People and funds that reported owning 5% or more of Precigen, newest first.
All reports
Every insider trade and SEC report we hold for Precigen.
Analysts, earnings and news
Analysts' price target
2 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected